Translational evidence shows that BCR-ABL mRNA can frequently be detected also in healthy individuals who will never develop CML [33, 34], suggesting that BCR-ABL alone may not suffice to transform directly. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.